International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-Tooth Disease type 1A treated 15 months
- Registry ID
- EUCTR2015-002378-19
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- PHARNEXT
- Start date
- 2015-08-04
- Completion date
- 2018-03-22
- Last update
- 2026-08-16
Conditions
- Charcot-Marie-Tooth Disease - Type 1A
Summary
To assess the efficacy of PXT3003 compared to Placebo on the disability measured by the ONLS score in CMT1A patients treated for 15 months.
Locations
- , , Spain
- , , France
- , , Netherlands
- , , Germany
- , , UK
- , , Belgium
View on source registry